摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethyl-2-((4-(ethylamino)-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-2,3-dihydro-1H-indene-2-carboxamide

中文名称
——
中文别名
——
英文名称
N-ethyl-2-((4-(ethylamino)-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-2,3-dihydro-1H-indene-2-carboxamide
英文别名
——
N-ethyl-2-((4-(ethylamino)-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-2,3-dihydro-1H-indene-2-carboxamide化学式
CAS
——
化学式
C30H33F3N8O2
mdl
——
分子量
594.64
InChiKey
WGGWZULYFUEHAJ-GOTSBHOMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.51
  • 重原子数:
    43.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    115.38
  • 氢给体数:
    3.0
  • 氢受体数:
    8.0

反应信息

  • 作为产物:
    描述:
    2-((4-chloro-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-N-ethyl-2,3-dihydro-1H-indene-2-carboxamide 、 乙胺盐酸盐N,N-二异丙基乙胺 作用下, 以 N-甲基吡咯烷酮 为溶剂, 以63%的产率得到N-ethyl-2-((4-(ethylamino)-6-(5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1,3,5-triazin-2-yl)amino)-2,3-dihydro-1H-indene-2-carboxamide
    参考文献:
    名称:
    Application of encoded library technology (ELT) to a protein–protein interaction target: Discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists
    摘要:
    The inhibition of protein-protein interactions remains a challenge for traditional small molecule drug discovery. Here we describe the use of DNA-encoded library technology for the discovery of small molecules that are potent inhibitors of the interaction between lymphocyte function-associated antigen 1 and its ligand intercellular adhesion molecule 1. A DNA-encoded library with a potential complexity of 4.1 billion compounds was exposed to the I-domain of the target protein and the bound ligands were affinity selected, yielding an enriched small-molecule hit family. Compounds representing this family were synthesized without their DNA encoding moiety and found to inhibit the lymphocyte function-associated antigen 1/intercellular adhesion molecule-1 interaction with submicromolar potency in both ELISA and cell adhesion assays. Re-synthesized compounds conjugated to DNA or a fluorophore were demonstrated to bind to cells expressing the target protein. (c) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2014.01.050
点击查看最新优质反应信息

文献信息

  • Application of encoded library technology (ELT) to a protein–protein interaction target: Discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists
    作者:Christopher S. Kollmann、Xiaopeng Bai、Ching-Hsuan Tsai、Hongfang Yang、Kenneth E. Lind、Steven R. Skinner、Zhengrong Zhu、David I. Israel、John W. Cuozzo、Barry A. Morgan、Koichi Yuki、Can Xie、Timothy A. Springer、Motomu Shimaoka、Ghotas Evindar
    DOI:10.1016/j.bmc.2014.01.050
    日期:2014.4
    The inhibition of protein-protein interactions remains a challenge for traditional small molecule drug discovery. Here we describe the use of DNA-encoded library technology for the discovery of small molecules that are potent inhibitors of the interaction between lymphocyte function-associated antigen 1 and its ligand intercellular adhesion molecule 1. A DNA-encoded library with a potential complexity of 4.1 billion compounds was exposed to the I-domain of the target protein and the bound ligands were affinity selected, yielding an enriched small-molecule hit family. Compounds representing this family were synthesized without their DNA encoding moiety and found to inhibit the lymphocyte function-associated antigen 1/intercellular adhesion molecule-1 interaction with submicromolar potency in both ELISA and cell adhesion assays. Re-synthesized compounds conjugated to DNA or a fluorophore were demonstrated to bind to cells expressing the target protein. (c) 2014 Elsevier Ltd. All rights reserved.
查看更多